{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
How has been the historical performance of Anthem Bioscienc?
Anthem Bioscienc experienced significant growth from March 2024 to March 2025, with net sales rising to 1,844.55 Cr and profit after tax increasing to 451.26 Cr. Key metrics such as operating profit and cash flow also improved, reflecting strong financial performance.
Is Anthem Bioscienc overvalued or undervalued?
As of August 29, 2025, Anthem Bioscienc is considered very expensive with a PE ratio of 90.82 and other high valuation metrics, indicating it is overvalued compared to peers, despite a recent positive return of 4.51%.
Is Anthem Bioscienc overvalued or undervalued?
As of August 29, 2025, Anthem Bioscienc is considered very expensive with a PE ratio of 90.82 and significantly higher valuation metrics compared to peers, indicating it is overvalued despite past strong returns.
Is Anthem Bioscienc overvalued or undervalued?
As of August 29, 2025, Anthem Bioscienc is considered very expensive and overvalued, with a PE Ratio of 90.82, an EV to EBITDA of 65.82, and a Price to Book Value of 18.59, all significantly higher than industry norms and its peers.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
